wide
rang
microorgan
replic
macrophag
cell
entri
pathogen
via
nonneutralis
igg
antibodi
complex
result
increas
intracellular
infect
idiosyncrat
signal
activ
receptor
usual
lead
phagocytosi
paradox
ligat
monocyt
macrophag
receptor
igg
immun
complex
rather
aid
host
defenc
suppress
innat
immun
increas
product
interleukin
bia
respons
respons
lead
increas
infecti
output
infect
cell
intrins
antibodydepend
enhanc
ade
infect
modul
sever
diseas
dispar
dengu
haemorrhag
fever
leishmaniasi
intrins
ade
distinct
extrins
ade
wherebi
complex
infecti
agent
nonneutralis
antibodi
lead
increas
number
infect
cell
intrins
ade
might
involv
mani
protozoan
bacteri
viral
infect
review
insight
intracellular
mechan
implic
enhanc
pathogenesi
ligat
macrophag
receptor
infecti
immun
complex
past
four
decad
inform
differ
line
scientif
inquiri
improv
understand
antibodymedi
mechan
modul
sever
correspond
dr
scott
b
halstead
edson
lane
north
bethesda
md
usa
halstead
erolscom
contributor
sbh
involv
literatur
review
data
interpret
write
edit
paper
sm
involv
write
paper
provid
intellectu
input
mam
involv
data
analysi
write
paper
prepar
figur
su
involv
write
paper
prepar
figur
dmm
involv
data
collect
interpret
develop
figur
infect
divers
microorgan
independ
studi
pathogenesi
cellular
host
respons
acut
chronic
human
anim
infecti
diseas
gener
evid
crosslink
immun
complex
receptor
increas
cellular
infect
contribut
diseas
sever
mechan
call
intrins
antibodydepend
enhanc
ade
infect
intrins
ade
distinct
extrins
ade
wherebi
complex
infecti
agent
nonneutralis
antibodi
lead
increas
number
infect
cell
hawk
made
earli
observ
studi
neutralis
murray
valley
enceph
viru
use
serumdilut
virusconst
method
chick
embryo
fibroblast
monolay
expos
viru
mix
high
dilut
chicken
antisera
plaqu
expos
viru
alon
followup
studi
find
seem
result
antibodi
stabilis
infect
murray
valley
enceph
viru
differ
explan
emerg
sequenti
infect
dengu
virus
result
dengu
haemorrhag
fever
monocyt
macrophag
identifi
main
host
dengu
infect
ade
implic
infect
murray
valley
enceph
viru
increas
ade
function
chicken
macrophag
identifi
chick
embryo
fibroblast
conform
requir
fc
receptor
termini
must
phylogenet
class
ade
chick
embryo
fibroblast
report
murray
valley
enceph
viru
antibodi
rais
chicken
mammal
monocyt
produc
bone
marrow
haemopoiet
stemcel
precursor
circul
bloodstream
day
half
cell
store
spleen
monocyt
matur
replenish
resid
macrophag
dendrit
cell
macrophag
scaveng
remov
wornout
cell
debri
also
present
antigen
initi
immun
respons
macrophag
receptor
lymphokin
enhanc
function
two
signal
need
produc
macrophag
activ
classic
pathway
interferon
tumour
necrosi
factor
tnf
interferon
exogen
toll
receptor
ligand
lipopolysaccharid
result
macrophag
abl
kill
intracellular
organ
macrophag
activ
classic
pathway
essenti
compon
host
defenc
system
activ
must
tightli
control
cytokin
mediat
produc
lead
host
tissu
damag
immunopatholog
disord
rheumatoid
arthriti
inflammatori
bowel
diseas
macrophag
great
plastic
respond
variou
environment
cue
adopt
mani
differ
state
activ
immun
respons
commonli
elicit
disturb
mucos
surfac
result
product
interleukin
interleukin
stimul
macrophag
secret
compon
extracellular
matrix
make
cell
effect
wound
heal
activ
woundheal
macrophag
produc
minimum
amount
proinflammatori
cytokin
less
effici
kill
intracellular
microb
macrophag
activ
classic
pathway
regulatori
macrophag
typic
aris
late
stage
adapt
immun
respons
primari
role
reduc
immun
respons
restrict
inflamm
cell
occur
respons
tolllik
receptor
stimul
presenc
glucocorticoid
prostaglandin
interleukin
immun
complex
regulatori
macrophag
program
produc
high
concentr
interleukin
suppress
product
interleukin
mani
uniqu
popul
activ
macrophag
distinct
phenotyp
like
aris
respons
specif
diseas
leishmaniasi
caus
protozoan
parasit
genu
leishmania
transmit
bite
sandfli
leishmania
speci
infect
mammal
caus
human
infect
diseas
exist
two
major
form
cutan
viscer
leishmaniasi
cutan
leishmaniasi
endem
mani
part
world
close
link
specif
geograph
regionswith
villag
littl
mile
apart
differ
infect
rate
viscer
leishmaniasi
also
known
kalaazar
sever
form
leishmaniasi
malaria
secondlead
caus
death
parasit
infect
estim
case
year
worldwid
leishmania
speci
close
link
human
be
commonli
report
citi
eg
l
chagasi
l
tropica
wherea
other
tradit
associ
anim
speci
classifi
zoonos
eg
l
major
leishmania
speci
transmit
promastigot
motil
form
infect
macrophag
spread
within
host
amastigot
oblig
parasit
macrophag
human
host
respons
infect
vari
leishmania
speci
patient
immun
reaction
patient
whose
lymphocyt
produc
high
amount
interferon
cell
usual
recov
cutan
infect
without
treatment
recoveri
patient
immun
reinfect
patient
infect
viscer
form
parasit
produc
high
titr
antibodi
contribut
host
defenc
without
treatment
patient
like
recov
viscer
leishmaniasi
mous
model
exist
studi
cutan
viscer
leishmaniasi
exampl
balbc
mice
suscept
diseas
develop
progress
nonheal
lesion
mani
intracellular
parasit
within
macrophag
despit
presenc
high
concentr
antiparasit
antibodi
parasit
usual
dissemin
liver
spleen
bone
marrow
thu
mimick
human
viscer
leishmaniasi
invitro
model
also
avail
promastigot
amastigot
infect
cultur
bone
marrow
periton
macrophag
mice
human
differenti
peripher
blood
mononuclear
cell
pbmc
sever
mammalian
cytokin
discov
among
cytokin
mous
cytokin
synthesi
inhibitori
factor
produc
cell
later
renam
interleukin
interleukin
type
cytokin
first
identifi
member
famili
cytokin
includ
interleukin
cytokin
similar
genom
organis
bind
receptor
similar
structur
case
share
compon
activ
janu
kinas
jak
signal
transduc
activ
transcript
stat
signal
pathway
interleukin
capabl
inhibit
synthesi
proinflammatori
cytokin
interferon
interleukin
tnf
granulocyt
macrophag
colonystimul
factor
interleukin
also
potent
abil
suppress
antigenpresent
capac
antigenpres
cell
howev
interleukin
alway
immunosuppress
cytokin
promot
surviv
natur
killer
cell
b
cell
product
bcell
antibodi
interleukin
made
macrophag
variou
cell
includ
tregulatori
cell
interleukin
import
role
regul
immun
respons
canal
increas
host
suscept
intracellular
infect
mous
model
cutan
leishmaniasi
suscept
l
major
associ
respons
cell
suscept
balbc
mice
produc
interleukin
infect
l
major
wherea
cell
resist
mice
express
interferon
interleukin
transient
deplet
cell
invivo
neutralis
interleukin
balbc
mice
promot
death
intracellular
parasit
recoveri
leishmani
lesion
interleukin
determin
suscept
howev
suscept
balbc
mice
express
interleukin
fulli
resist
infect
furthermor
peopl
dichotomi
pronounc
interleukin
seem
major
induc
suscept
peopl
viscer
leishmaniasi
interleukin
titr
plasma
directli
correl
diseas
sever
interleukin
found
lymph
node
taken
patient
viscer
leishmaniasi
furthermor
pbmc
patient
acut
viscer
leishmaniasi
respond
stimul
leishmania
lysat
produc
interleukin
mrna
ad
pbmc
interleukin
suppress
product
interferon
interleukin
wherea
treatment
antiinterleukin
pbmc
patient
acut
viscer
leishmaniasi
substanti
increas
prolif
respons
leishmania
lysat
result
invitro
studi
periton
bone
marrow
macrophag
infect
leishmania
speci
show
intracellular
kill
organ
macrophag
activ
classic
pathway
inhibit
treatment
exogen
interleukin
endogen
macrophag
product
interleukin
interleukin
complementari
role
interleukin
act
directli
cell
enhanc
prime
product
revers
prime
potent
cytokin
induct
leishmanicid
activ
macrophag
interferon
sustain
product
interferon
respons
infect
commonli
associ
develop
specif
respons
mice
infect
l
major
treatment
interleukin
increas
product
reduc
sever
diseas
potenti
vaccinederiv
immun
suppress
product
howev
exposur
macrophag
suscept
mice
opsonis
leishmania
promastigot
suppress
express
interleukin
bonemarrowderiv
macrophag
balbc
mice
product
interleukin
respons
lipopolysaccharid
suppress
ligat
fc
complement
scaveng
receptor
mrna
synthesi
protein
secret
diminish
almost
undetect
level
receptor
ligat
tnf
product
inhibit
suppress
specif
interleukin
addit
ligat
mous
receptor
immun
complex
increas
product
interleukin
stimul
mous
bonemarrow
macrophag
lipopolysaccharid
result
product
addit
red
blood
cell
opsonis
igg
antibodi
substanti
increas
product
immun
complex
induc
activ
macrophag
produc
interleukin
also
induc
macrophag
dendrit
cell
stop
product
interleukin
interleukin
macrophag
modul
differ
mechan
abrog
biosynthesi
properti
share
ligat
sever
macrophag
receptor
induct
interleukin
specif
receptor
addit
evid
role
interleukin
promot
chronic
infect
provid
observ
normal
balbc
mice
develop
progress
nonheal
lesion
mani
l
major
parasit
wherea
balbc
mice
express
interleukin
control
diseas
progress
small
lesion
fewer
parasit
week
infect
furthermor
establish
l
donovani
viscer
infect
wildtyp
mice
treatment
monoclon
antibodi
either
interleukin
receptor
success
induc
intracellular
parasit
kill
within
liver
macrophag
find
studi
indic
amastigot
leishmania
exploit
unusu
unexpect
virul
factor
host
igg
surfac
leishmania
amastigot
coat
igg
result
immun
complex
allow
ligat
receptor
inflammatori
macrophag
preferenti
induc
product
high
amount
interleukin
induct
interleukin
iggamastigot
complex
occur
macrophag
deriv
mice
common
chain
signal
receptor
indic
one
three
receptor
involv
result
subsequ
studi
use
defin
immun
complex
indic
three
receptor
signal
gamma
chain
capabl
signal
product
macrophag
therefor
set
igg
seem
bia
immun
respons
toward
respons
speci
leishmania
persist
infect
depend
whether
amastigot
coat
igg
product
interleukin
ligat
receptor
gener
process
requir
nonmicrobi
antigen
expos
ovalbumin
alon
lipopolysaccharidetr
balbc
mous
macrophag
develop
tcell
respons
characteris
product
interferon
antigen
complex
igg
antiovalbumin
respons
predomin
product
interleukin
phenotyp
stabl
retain
cell
subsequ
stimul
nonbias
condit
mice
vaccin
iggopsonis
ovalbumin
produc
high
titr
igg
antibodi
isotyp
tcell
bias
revers
via
receptor
ligat
also
seen
vivo
macrophag
knockout
mice
product
interferon
cell
control
macrophag
cytokin
interleukin
product
interleukin
interleukin
find
show
ligat
fc
receptor
activ
macrophag
revers
bias
accompani
innat
immun
respons
microbi
product
patient
viscer
leishmaniasi
high
titr
leishmani
antibodi
correl
peak
parasitaemia
neg
delayedtyp
hypersensit
respons
success
treatment
leishmaniasi
amphotericin
b
result
decreas
antibodi
titr
restor
delayedtyp
hypersensit
respons
earlier
observ
identifi
polyclon
bcell
activ
high
concentr
immun
complex
well
rheumatoid
factor
patient
viscer
leishmaniasi
small
seri
individu
infect
l
donovani
like
develop
rheumatoid
arthriti
noninfect
control
experiment
model
viscer
leishmaniasi
infect
hamster
develop
immun
complex
glomerulonephr
addit
l
donovoni
l
major
humor
immun
respons
l
mexicana
effect
kill
organ
hide
parasitophor
vacuol
host
iggcoat
amastigot
gener
immunosuppress
respons
infect
macrophag
although
perhap
caus
differ
mechan
similar
process
might
involv
jhd
mice
infect
l
amazonensi
one
studi
infect
minimis
absenc
b
cell
antibodi
immun
element
restor
lesion
progress
process
thought
involv
cell
antibodyco
amastigot
result
product
interleukin
macrophag
ligat
macrophag
receptor
produc
rapid
enhanc
activ
two
mitogenactiv
protein
kinas
mapk
extracellular
signalregul
kinas
erk
activ
erk
lead
phosphoryl
serin
histon
gene
encod
interleukin
increas
access
promot
transcript
factor
gener
respons
activ
figur
activ
mapk
need
synthesi
addit
erk
activ
inflammatori
stimulu
lowmolecularweight
hyaluron
acid
extracellular
matrix
need
combin
two
signal
result
superinduct
interleukin
macrophag
receptor
macrophag
treat
inhibitor
spleen
tyrosin
kinas
activ
ligat
activ
erk
fail
produc
interleukin
infect
leishmania
speci
amastigot
mani
bacteria
replic
partli
sole
human
macrophag
mani
organ
infect
macrophag
produc
chronic
infect
one
criteria
success
parasit
microorgan
produc
system
infect
might
abil
evad
microbicid
mechan
macrophag
defens
mechan
much
studi
chronic
infect
success
infect
microorgan
similar
antigen
structur
might
contribut
format
pathogen
igg
immun
complex
control
microbi
surviv
infect
might
analog
leishmania
model
includ
mycobacterium
tuberculosi
mycobacterium
lepra
legionella
pneumophila
listeria
monocytogen
brucella
spp
salmonella
spp
shigella
spp
coxiella
burnetii
anaplasma
phagocytophilum
ehrlichia
chaffeensi
anoth
protozoan
toxoplasma
gondii
fungi
eg
histoplasma
capsulatum
role
fc
receptor
immun
complex
studi
exhaust
organ
although
studi
resist
tuberculosi
focus
tcell
immun
mice
defici
inhibitori
receptor
iib
improv
bacteri
control
diminish
patholog
chang
day
day
aerosol
challeng
tuberculosi
mice
defici
receptor
iib
increas
product
subunit
interleukin
interleukin
subunit
common
promot
polaris
naiv
cell
effector
treatment
human
macrophag
exogen
interleukin
combin
blockad
interleukin
reduc
burden
mycobacteri
infect
infect
characteris
larg
protect
respons
coincid
increas
activ
macrophag
human
be
high
concentr
interleukin
relat
suppress
host
defenc
mechan
exacerb
infect
model
reactiv
tuberculosi
presenc
macrophagederiv
interleukin
lung
infect
transgen
mice
enabl
cell
effici
express
effector
function
secret
suffici
interferon
induc
activ
macrophag
classic
pathway
characteris
express
induc
nitric
oxid
synthas
induc
protein
member
formerli
howev
mycobacteria
surviv
success
prolifer
within
mous
macrophag
product
control
human
promot
macrophagederiv
interleukin
seem
overrid
activ
macrophag
classic
pathway
effector
mechan
tuberculosi
induc
altern
activ
phenotyp
far
specif
contribut
tuberculosisigg
antibodi
complex
toward
modul
infect
model
system
unknown
ade
mechan
attract
wide
interest
virolog
mani
virus
replic
macrophag
vivo
caus
enhanc
infect
diseas
sever
viral
infect
irrefut
link
antibodi
enhanc
infect
need
initi
immunolog
event
term
sensitis
viral
infect
categoris
two
group
virus
caus
immun
respons
sensitis
host
result
sequenti
infect
one
antigen
type
result
rapid
evolut
antigen
divers
cours
chronic
infect
tabl
host
sensitis
virus
given
kill
vaccin
tabl
respiratori
syncyti
measl
virus
infect
respiratori
epitheli
cell
vivo
enhanc
infect
observ
individu
given
kill
viral
vaccin
caus
ade
attribut
poor
antibodi
qualiti
result
aberr
antigen
present
initi
ade
research
increas
yield
viru
assum
result
higher
number
cell
infect
presenc
antibodi
absenc
antibodi
increas
infect
shown
mediat
receptor
exampl
west
nile
viru
particl
shown
attach
surfac
mous
macrophag
immun
complex
nake
viru
felin
infecti
periton
viru
periton
macrophag
infect
vitro
presenc
antibodi
absenc
antibodi
altern
immun
complex
might
internalis
rapidli
viru
alon
viral
replic
initi
progeni
virus
releas
sooner
cell
pretreat
hivspecif
antibodi
cell
expos
untreat
viru
protein
rna
synthesi
increas
cell
infect
immun
complex
viru
alon
acut
infect
ross
river
viru
rrv
often
result
postinfect
arthriti
arthralgia
mani
month
synovi
cell
typic
stain
rrv
antigen
wherea
synovi
fluid
often
contain
interferon
tnf
attempt
made
model
find
establish
chronic
rrv
infect
mous
macrophag
line
infect
cell
might
model
rrv
persist
synovi
tissu
produc
arthriti
arthralgia
incub
rrv
dilut
rrv
antiserum
result
increas
infect
cell
find
confirm
human
monocyt
cell
line
mono
mac
primari
human
monocyt
macrophag
rrvinfect
raw
continu
mous
macrophag
cell
produc
antivir
tnf
treat
lipopolysaccharid
cell
infect
via
ade
pathway
tnf
product
abrog
rrv
infect
greatli
enhanc
increas
ade
product
viru
correl
downregul
nitric
oxid
product
inhibit
transcript
gene
tnf
interferon
regulatori
factor
nuclear
factor
tnf
gene
transcript
protein
synthesi
decreas
gener
protein
synthesi
increas
transcript
nonantivir
control
gene
one
studi
ademedi
infect
lipopolysaccharidetr
raw
cell
result
substanti
increas
rrvinfect
cell
compar
virusonli
control
h
although
adeinfect
cell
stain
rrv
antigen
immunofluoresc
microscopi
greater
percentag
cell
posit
pcr
electron
microscopi
rrv
ade
infect
suppress
signal
interferoninduc
protein
tnf
interferon
human
genet
transcript
factor
regul
immun
respons
substanti
increas
gene
transcript
protein
product
cell
report
crucial
inhibit
antivir
factor
transcript
requir
infecti
viru
immun
igg
complex
sinc
ligat
receptor
zymosanantibodi
complex
ablat
antivir
transcript
dengu
virus
group
four
close
relat
member
flaviviru
genu
share
genet
homolog
inocul
bite
infect
aed
aegypti
initi
infect
rais
crossreact
nonneutralis
antibodi
enhanc
infect
differ
viru
type
data
invitro
studi
fc
receptorbear
cell
indic
specif
monoclon
dengu
antibodi
might
form
infecti
immun
complex
major
requir
antibodi
concentr
need
neutralis
practic
antibodi
direct
surfac
epitop
involv
viru
entri
effici
produc
ade
fact
infant
might
acquir
sever
dengu
diseas
first
dengu
infect
placent
acquir
matern
polyclon
dengu
antibodi
diminish
protect
concentr
uniqu
exampl
ade
result
studi
human
tissu
establish
monocyt
macrophag
immatur
matur
dendrit
cell
major
target
dengu
viru
infect
human
be
secondari
dengu
infect
follow
stereotyp
cours
sever
outcom
shock
gastrointestin
haemorrhag
accompani
vascular
collaps
result
capillari
permeabl
around
time
defervesc
indirect
evid
suggest
cytokin
mediat
vascular
permeabl
patient
dengu
infect
much
work
focus
measur
blood
cytokin
concentr
patient
late
acut
phase
onset
shock
elev
viraemia
high
concentr
proinflammatori
immunomodulatori
cytokin
includ
interleukin
associ
sever
diseas
invitro
ade
infect
cell
human
monocyt
receptorbear
continu
cell
line
intracellular
dengu
viru
product
increas
result
idiosyncrat
signal
infect
polyclon
antibodi
plu
dengu
viru
result
suppress
innat
respons
ligat
receptor
receptor
iia
entri
infecti
immun
complex
activ
express
neg
regul
dihydroxyaceton
kinas
autophagi
protein
retino
acidinduc
protein
imelanoma
differentiationassoci
gene
result
downregul
signal
pathway
decreas
product
type
interferon
interferonactiv
antivir
molecul
ligat
fc
receptor
dengu
viru
infect
activ
product
earli
phase
infect
suppress
role
interleukin
ade
infect
confirm
induc
bias
also
inhibit
potent
suppressor
jakstat
signal
pathway
via
suppressor
cytokin
signal
soc
system
result
two
suppress
pathway
adeinfect
cell
secret
low
concentr
type
interferon
thu
suppress
transcript
translat
interleukin
interferon
tnf
facilit
express
synthesi
antiinflammatori
cytokin
pathway
infect
also
suppress
innat
dengu
viru
mediat
nitric
oxid
radic
disrupt
transcript
gene
transcript
factor
thu
ade
infect
facilit
viru
entri
extrins
ade
also
modifi
innat
adapt
intracellular
antivir
mechan
enhanc
replic
intrins
ade
figur
human
invivo
correl
made
invitro
respons
acut
sever
ill
stage
secondari
infect
increas
product
interleukin
accompani
downregul
sever
interferon
regulatori
gene
genomewid
transcriptom
pbmc
collect
acut
phase
mild
dengu
fever
dengu
haemorrhag
fever
children
compar
use
microarray
analysi
compar
patient
milder
ill
dengu
haemorrhag
fever
secondari
infect
low
concentr
nitric
oxid
low
interferon
transcript
pbmc
high
blood
concentr
cdna
array
indic
immun
respons
gene
strongli
upregul
pbmc
children
mild
ill
interferoninduc
interferoninduc
gene
robust
upregul
type
interferon
gene
pbmc
children
mild
ill
accompani
increas
plasma
concentr
interferon
gene
upregul
product
substanti
increas
patient
mild
dengu
ill
compar
patient
sever
dengu
ill
notabl
abund
interferon
interferoninduc
factor
patient
mild
diseas
consist
protect
role
interferon
control
dengu
infect
indic
mous
model
suggest
human
be
dengu
fever
patient
surviv
dengu
haemorrhag
fever
higher
concentr
circul
interferon
die
patient
dengu
fever
lower
peak
viraemia
titr
dengu
haemorrhag
fever
role
anoth
interferonrel
mediat
reduc
viral
load
dengu
fever
suggest
product
human
upregul
pbmc
patient
dengu
fever
mous
model
protect
dengu
infect
serv
chemoattract
natur
killer
cell
block
interact
dengu
put
receptor
heparan
sulphat
woundheal
macrophag
readili
support
infect
four
dengu
virus
vitro
human
monocyt
activ
macrophag
matur
dendrit
cell
express
ade
wherea
immatur
dendrit
cell
marovich
unpublish
macrophag
dengu
viru
infect
produc
high
concentr
type
interferon
downregul
ade
condit
replac
secret
proinflammatori
cytokin
interleukin
peak
enhanc
titr
matur
dendrit
cell
secret
interferon
coincid
peak
ade
immatur
dendrit
cell
readili
infect
dengu
viru
alon
process
effici
mediat
attach
molecul
dendrit
cellspecif
intercellular
adhes
nonintegrin
dcsign
monocyt
secret
interleukin
ade
infect
serum
dilut
produc
peak
viru
marovich
unpublish
product
protein
control
promot
polymorph
three
singl
nucleotid
polymorph
flank
region
interleukin
posit
ag
ct
ca
studi
dengu
infect
rate
enhanc
titr
remark
consist
primari
monocyt
differ
donor
homozyg
gcc
haplotyp
associ
high
secret
wherea
donor
acc
haplotyp
produc
intermedi
concentr
interleukin
ata
haplotyp
secret
lowest
concentr
precis
role
product
induc
immun
complex
clinic
event
dengu
infect
known
report
shift
respons
respons
sever
secondari
dengu
ill
could
attribut
interleukin
use
mous
model
indic
aderel
earli
vascular
permeabl
mediat
tnf
contribut
respons
vascular
permeabl
mice
unknown
asia
america
preced
infect
immunis
nondengu
flaviviru
japanes
enceph
asia
yellow
fever
yellow
fever
vaccin
americasdo
predispos
individu
dengu
haemorrhag
fever
subsequ
dengu
viru
infect
although
nondengu
flaviviru
antibodi
form
infecti
immun
complex
dengu
virus
invitro
studi
cell
late
convalesc
sera
individu
infect
japanes
enceph
viru
lead
ade
infect
dengu
viru
nonneutralis
heterotyp
flavivir
antibodi
gener
nonneutralis
therefor
attach
part
virion
crucial
neutralis
might
site
attach
antibodi
virion
control
outcom
intrins
ade
ade
viru
infect
might
diseaseenhanc
factor
sever
human
anim
viral
diseas
attribut
diseas
summaris
tabl
section
briefli
review
three
diseas
particular
felin
infecti
periton
aleutian
diseas
mink
porcin
reproduct
respiratori
syndrom
prr
felin
infecti
periton
caus
coronaviru
replic
macrophag
lead
periton
occasion
fatal
pyogranulomat
diseas
kitten
cat
ade
incrimin
diseaseenhanc
factor
cat
activ
diseas
acquir
passiv
matern
antibodi
develop
rapid
fulmin
diseas
challeng
viru
seroneg
cat
diseas
enhanc
report
kitten
vaccinederiv
humor
immun
direct
spike
protein
felin
infecti
periton
viru
similarli
kitten
immunis
recombin
vaccinia
viru
express
spike
protein
viru
die
earlier
control
anim
felin
infecti
periton
viru
deriv
chronic
infect
felin
coronavirus
cours
viru
mutat
present
new
antigen
host
kitten
die
earlier
control
anim
aleutian
diseas
mink
caus
parvoviru
pathogen
mink
replic
macrophag
circul
blood
mainli
fulli
infecti
immun
complex
vivo
vitro
deposit
solubl
immun
complex
renal
glomerular
membran
wall
capillari
blood
vessel
lead
fatal
glomerulonephr
ade
might
import
contribut
factor
pathogenesi
diseas
aleutian
diseas
viru
replic
macrophag
infect
mink
produc
larg
amount
nonneutralis
antibodi
antibodi
subsequ
produc
infecti
immun
complex
lead
increas
infect
macrophag
passiv
transfer
virusspecif
antibodi
peak
viral
replic
result
foci
necrosi
around
virusinfect
cell
reaction
thought
due
complementmedi
cytolysi
infecti
immun
complex
result
increas
infect
mink
periton
macrophag
one
studi
inocul
experiment
kill
aleutian
diseas
viru
vaccin
produc
detect
neutralis
antibodi
although
eight
ten
vaccin
mink
control
anim
develop
diseas
challeng
live
viru
prr
caus
member
arteriviru
genu
coronaviru
famili
first
isol
netherland
classifi
syndrom
recognis
usa
call
mysteri
swine
diseas
also
call
blue
ear
diseas
two
prototyp
strain
prr
viru
european
north
american
caus
similar
clinic
symptom
distinct
viral
genotyp
whose
genom
diverg
genet
variat
among
virus
vari
geograph
increas
difficulti
vaccin
develop
reason
understood
diseas
present
vari
one
herd
anoth
everi
three
herd
expos
prr
first
exposur
one
herd
show
recognis
diseas
second
might
show
mild
diseas
third
show
moder
sever
diseas
better
health
statu
herd
less
sever
diseas
evid
exist
prr
viru
mutat
multipli
lead
strain
highli
virul
prr
viru
particular
affin
macrophag
particularli
lung
viru
multipli
macrophag
kill
cell
prr
viru
infect
often
chronic
herd
infect
viru
tend
remain
present
activ
indefinit
macrophagetrop
organ
discuss
review
evolv
variou
offens
mechan
case
mechan
suffici
reduc
host
defenc
mechan
case
receptormedi
intrins
ade
might
also
result
either
sever
sustain
infect
case
host
tcell
respons
quickli
predomin
effect
control
infect
robust
resist
reinfect
achiev
differenti
outcom
clear
complex
characteris
interact
infecti
pathogen
antibodi
exampl
mahalingam
lidburi
ad
irrelev
noninfecti
immun
complex
mous
macrophag
cell
line
infect
cell
rrv
ade
occurdespit
report
respons
ligat
receptor
igg
immun
complex
gener
process
ade
lead
prolifer
lymphocyt
specif
outcom
ligat
human
receptor
immun
complex
need
care
studi
mani
year
ago
antibodylik
molecul
recognis
attach
primari
monocyt
obtain
dengueimmun
donor
present
understand
human
receptor
could
cytophil
antibodi
attach
highaffin
receptor
interest
question
whether
cytophil
noncytophil
immun
complex
mediat
enhanc
sever
dengu
diseas
furthermor
intrins
ade
result
interact
immun
complex
receptor
iib
inhibitori
fc
receptor
sever
line
evid
suggest
monocytemacrophag
interact
infecti
viru
infecti
virusantibodi
complex
differ
earli
stage
infect
mutat
form
fc
portion
polyval
dengu
viru
monoclon
antibodi
abolish
fcreceptor
bind
neutralis
activ
instead
enhanc
activ
moreov
function
fc
portion
need
complet
cytoplasm
tail
fc
receptor
essenti
dengu
virusantibodi
complex
promot
enhanc
activ
indic
fact
disrupt
immun
tyrosin
activ
motif
itam
remov
sequenc
two
itam
region
abolish
ade
activ
howev
innat
immun
respons
suppress
simpli
crosslink
fc
receptor
antibodi
ubol
unpublish
henc
enhanc
effect
virusantibodi
complex
might
start
fc
portion
engag
fc
receptor
turn
switch
neg
regulatori
innat
immun
respons
event
occur
entri
nake
viru
intrins
ade
link
immunobiolog
interleukin
complex
type
ii
cytokin
key
role
mani
infecti
process
result
invitro
experi
suggest
earli
product
interleukin
dengu
infect
might
import
role
promot
ade
wherea
interleukin
produc
latter
half
secondari
dengu
infect
might
immunoregulatori
care
studi
follow
individu
cours
primari
mild
secondari
sever
dengu
infect
need
event
simpli
accompani
secondari
immun
respons
distinguish
respons
might
contribut
immunopatholog
chang
sever
question
concern
essenti
nonessenti
compon
intrins
ade
exactli
product
fit
process
product
lead
increas
infect
initi
infect
cell
interleukin
mainli
function
bystand
cell
function
differ
interleukin
tcell
macrophag
origin
anoth
profound
effect
interleukin
inhibit
product
proinflammatori
cytokin
mediat
macrophag
dendrit
cell
major
inflammatori
cytokin
interleukin
tnf
substanti
repress
exposur
interleukin
mani
perhap
fundament
characterist
intrins
ade
unknown
studi
intrins
ade
expand
understand
mechan
pathogenesi
broad
rang
infecti
diseas
open
mani
approach
tolllik
receptor
tlr
signal
adaptor
molecul
myeloid
differenti
primari
respons
gene
activ
kinas
cascad
result
activ
nuclear
factor
pathway
lead
activ
transcript
factor
potenti
bind
interleukin
promot
rest
cell
promot
inaccess
transcript
factor
tightli
pack
chromatin
b
ligat
receptor
signal
differ
protein
kinas
syk
activ
extracellular
signalregul
kinas
erk
pathway
lead
phosphoryl
chromatin
make
promot
access
transcript
factor
irak
receptor
associ
kinas
receptorassoci
factor
kinas
essenti
modul
pkcprotein
kinas
c
attach
entri
infecti
virusantibodi
complex
fc
receptorbear
cell
result
increas
product
viru
inhibit
type
interferon
product
proinflammatori
cytokin
addit
biosynthesi
activ
stimul
member
suppressor
cytokin
signal
soc
famili
result
suppress
janu
kinasesign
transduc
activ
transcript
jakstat
signal
pathway
bia
toward
respons
contrast
infect
nake
viru
via
virusspecif
receptor
signal
pattern
recognit
receptor
prr
produc
intracellular
antivir
molecul
adeantibodydepend
enhanc
helper
denvdengu
viru
tabl
virus
caus
invitro
antibodydepend
enhanc
infect
antibodyenhanc
diseas
evid
invivo
enhanc
respiratori
syncyti
viru
measl
rabi
effect
human
be
evid
domest
wild
anim
prrsvporcin
reproduct
respiratori
syndrom
posit
effect
unknown
effect
